IZIlyess Zemmoura

Ilyess Zemmoura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ilyess Zemmoura has a total of 279 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reconstruction des fibres blanches cérébrales à partir de la dissection et recalage dans l'IRM post-mortem : pour la comparaison à la tractographie cérébrale par IRM de diffusion

    by Ilyess Zemmoura

    La connaissance de la morphologie des faisceaux de fibres blanches, qui connectent des régions cérébrales distantes, est indispensable à la compréhension du fonctionnement cérébral. La tractographie par IRM de diffusion reconstruit indirectement cette anatomie à partir d'algorithmes mathématiques complexes. Après une revue des méthodes proposées pour la validation de la tractographie, nous proposons une méthode originale basée sur la reconstruction 3D de faisceaux disséqués. Notre méthode, FIBRASCAN, utilise des acquisitions itératives de surface en cours de dissection. Les faisceaux étaient segmentés sur chaque surface puis reconstruits par empilement. Un support rigide permettait le recalage entre surfaces puis vers l'IRM. Nous avons démontré la précision de chaque étape de reconstruction, et sa faisabilité sur plusieurs faisceaux. Dans la dernière partie de ce travail, la structure des fibres blanches et les modifications induites par la préparation et la dissection sont explorées en microscopie électronique. Nous avons montré que la dissection préservait la structure des axones et peut ainsi être considérée comme un outil de validation de la tractographie.

  • Primary central nervous system lymphoma: A 7 years single-center experience

    by Etienne Dugast, Cédric Aumont, Ilyess Zemmoura

  • Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation study

    by Nicolas Roquet, Arnaud Beddok, Maxime Loo, Gilles Calais, Gilles Créhange, Ilyes Zemmoura, Catherine Horodyckid, Sophie Chapet, Thomas Frédéric-Moreau

    This study investigated hypofractionated stereotactic radiotherapy (HSRT) for resected brain metastases and how the dose-fractionation affects local control (LC) and radionecrosis (RN). We retrospectively evaluated patients with brain metastases who were treated between 2010 and 2023. Post-operative HSRT was delivered in three or five fractions. The primary objective was to determine the effect of dose escalation and fractionation on LC. Secondary objectives included identifying factors associated with RN. Statistical analyses were conducted using Chi-square or Fisher’s exact tests for categorical data and Mann-Whitney U tests for continuous variables (significance level: p < 0.05). After a median follow-up of 19 months, 34 patients out of 212 (16%) had local recurrence. A biologically effective dose (BED10) > 28.8 Gy was associated with better LC (p = 0.002), but no benefit was found for a BED10 > 48 Gy. RN developed in 34 patients (16%). A prescription BED10 > 48 Gy was associated with an increased incidence of symptomatic RN (p = 0.002). For HSRT in three fractions, a CTV D99% ≥ 29 Gy significantly improved the LC (p = 0.04), and V30Gy, V23.1 Gy, and V18Gy were significantly associated with an increased risk of RN. The fractionation was not found to affect the LC or RN. This large, retrospective cohort study on post-operative HSRT indicates that a BED10 of 40.9–48 Gy (3 × 7,7 Gy or 5 × 6 Gy) to the planning target volume results in excellent LC while limiting the risk of RN. No difference in LC or RN was found for different fractionations.


  • Open Access

    Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage: A Review

    by Nourou Dine Adeniran Bankole, Cyrille Kuntz, Alexia Planty-Bonjour, Quentin Beaufort, Thomas Gaberel, Charlotte Cordonnier, Marco Pasi, Frieder Schlunk, Jawed Nawabi, Ilyess Zemmoura, et al.

    Background: Spontaneous intracerebral hemorrhage (ICH) accounts for approximately 20% of all strokes and is associated with high mortality and disability rates. Despite numerous trials, conventional surgical approaches have not demonstrated consistent improvements in functional outcomes. Minimally invasive surgery (MIS) for ICH evacuation has emerged as a promising alternative, with the potential to improve functional outcomes and reduce mortality. Objectives: This narrative review aims to provide a comprehensive overview of various MIS techniques and their reported impact on functional outcomes in patients with spontaneous ICH while discussing key limitations in the existing literature. Methods: We systematically searched PubMed to identify studies published from 1 January 2010 to 22 March 2024. The search strategy included the following terms: (“minimally*”[All Fields] AND “invasive*”[All Fields] AND “surgery*”[All Fields] AND “intracerebral*”[All Fields] AND “hemorrhage*”[All Fields]) AND (2010:2024[pdat]). This review focuses on randomized controlled trials (RCTs) that evaluate MIS techniques for ICH and their clinical outcomes. Results: Our search identified six RCTs conducted between January 2010 and March 2024, encompassing 2180 patients with a mean age of 58.03 ± 4.5 years. Four trials demonstrated significantly improved functional recovery (mRs ≤ 3), reduced mortality, and fewer adverse events compared with standard medical management or conventional craniotomy. All MIS techniques rely on stereotactic planning and the use of tools such as exoscopes, endoscopes, craniopuncture, or thrombolytic irrigation for precise hematoma evacuation. These approaches reduce brain tissue disruption and improve precision. However, the variability in techniques, costs, and lack of an external validation limit the generalizability of these findings. Conclusions: MIS shows potential as an alternative to conventional management strategies for ICH, offering encouraging evidence for improved functional outcomes and reduced mortality in selected studies. However, these findings remain limited by gaps in the literature, including the need for external validation, significant methodological heterogeneity, and economic challenges. Further rigorous trials are essential to confirm the generalizability and long-term impact of these approaches.


  • Open Access

    Deep Learning-Based Glioma Segmentation of 2D Intraoperative Ultrasound Images: A Multicenter Study Using the Brain Tumor Intraoperative Ultrasound Database (BraTioUS)

    by Santiago Cepeda, Olga Esteban-Sinovas, Vikas Singh, Prakash Shetty, Aliasgar Moiyadi, Luke Dixon, Alistair Weld, Giulio Anichini, Stamatia Giannarou, Sophie Camp, et al.

    Background: Intraoperative ultrasound (ioUS) provides real-time imaging during neurosurgical procedures, with advantages such as portability and cost-effectiveness. Accurate tumor segmentation has the potential to substantially enhance the interpretability of ioUS images; however, its implementation is limited by persistent challenges, including noise, artifacts, and anatomical variability. This study aims to develop a convolutional neural network (CNN) model for glioma segmentation in ioUS images via a multicenter dataset. Methods: We retrospectively collected data from the BraTioUS and ReMIND datasets, including histologically confirmed gliomas with high-quality B-mode images. For each patient, the tumor was manually segmented on the 2D slice with its largest diameter. A CNN was trained using the nnU-Net framework. The dataset was stratified by center and divided into training (70%) and testing (30%) subsets, with external validation performed on two independent cohorts: the RESECT-SEG database and the Imperial College NHS Trust London cohort. Performance was evaluated using metrics such as the Dice similarity coefficient (DSC), average symmetric surface distance (ASSD), and 95th percentile Hausdorff distance (HD95). Results: The training cohort consisted of 197 subjects, 56 of whom were in the hold-out testing set and 53 in the external validation cohort. In the hold-out testing set, the model achieved a median DSC of 0.90, ASSD of 8.51, and HD95 of 29.08. On external validation, the model achieved a DSC of 0.65, ASSD of 14.14, and HD95 of 44.02 on the RESECT-SEG database and a DSC of 0.93, ASSD of 8.58, and HD95 of 28.81 on the Imperial-NHS cohort. Conclusions: This study supports the feasibility of CNN-based glioma segmentation in ioUS across multiple centers. Future work should enhance segmentation detail and explore real-time clinical implementation, potentially expanding ioUS’s role in neurosurgical resection.


  • Open Access

    Prognostic Modeling of Overall Survival in Glioblastoma Using Radiomic Features Derived from Intraoperative Ultrasound: A Multi-Institutional Study

    by Santiago Cepeda, Olga Esteban-Sinovas, Vikas Singh, Aliasgar Moiyadi, Ilyess Zemmoura, Massimiliano Del Bene, Arianna Barbotti, Francesco DiMeco, Timothy Richard West, Brian Vala Nahed, et al.

    Background: Accurate prognostic models are essential for optimizing treatment strategies for glioblastoma, the most aggressive primary brain tumor. While other neuroimaging modalities have demonstrated utility in predicting overall survival (OS), intraoperative ultrasound (iUS) remains underexplored for this purpose. This study aimed to evaluate the prognostic potential of iUS radiomics in glioblastoma patients in a multi-institutional cohort. Methods: This retrospective study included patients diagnosed with glioblastoma from the multicenter Brain Tumor Intraoperative (BraTioUS) database. A single 2D iUS slice, showing the largest tumor diameter, was selected for each patient. Radiomic features were extracted and subjected to feature selection, and clinical data were collected. Using a fivefold cross-validation strategy, Cox proportional hazards models were built using radiomic features alone, clinical data alone, and their combination. Model performance was assessed via the concordance index (C-index). Results: A total of 114 patients met the inclusion criteria, with a mean age of 56.88 years, a median OS of 382 days, and a median preoperative tumor volume of 32.69 cm3. Complete tumor resection was achieved in 51.8% of the patients. In the testing cohort, the combined model achieved a mean C-index of 0.87 (95% CI: 0.76–0.98), outperforming the radiomic model (C-index: 0.72, 95% CI: 0.57–0.86) and the clinical model (C-index: 0.73, 95% CI: 0.60–0.87). Conclusions: Intraoperative ultrasound relies on acoustic properties for tissue characterization, capturing unique features of glioblastomas. This study demonstrated that radiomic features derived from this imaging modality have the potential to support the development of survival models.


  • Asleep-awake-asleep versus hypnosis for low-grade glioma surgery: long term follow-up outcome

    by Nourou Dine Adeniran Bankole, Ulrick Sidney Kanmounye, Abdessamad El Ouahabi, Ilyess Zemmoura


  • Open Access

    Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis

    by Débora Lanznaster, Clément Bruno, Jérôme Bourgeais, Patrick Emond, Ilyess Zemmoura, Antoine Lefèvre, Pascal Reynier, Sébastien Eymieux, Emmanuelle Blanchard, Patrick Vourc'H, et al.

    Diverse biomarkers and pathological alterations have been found in muscle of patients with Amyotrophic lateral sclerosis (ALS), but the relation between such alterations and dysfunction in energetic metabolism remains to be investigated. We established the metabolome of muscle and serum of ALS patients and correlated these findings with the clinical status and pathological alterations observed in the muscle. We obtained data from 20 controls and 17 ALS patients (disease duration: 9.4 ± 6.8 months). Multivariate metabolomics analysis identified a distinct serum metabolome for ALS compared to controls (p-CV-ANOVA < 0.035) and revealed an excellent discriminant profile for muscle metabolome (p-CV-ANOVA < 0.0012). Citramalate was discriminant for both muscle and serum. High lauroylcarnitine levels in muscle were associated with low Forced Vital Capacity. Transcriptomics analysis of key antioxidant enzymes showed an upregulation of SOD3 (p = 0.0017) and GLRX2(1) (p = 0.0022) in ALS muscle. Analysis of mitochondrial enzymatic activity in muscle revealed higher complex II/CS (p = 0.04) and lower LDH (p = 0.03) activity in ALS than in controls. Our study showed, for the first time, a global dysfunction in the muscle of early-stage ALS patients. Furthermore, we identified novel metabolites to be employed as biomarkers for diagnosis and prognosis of ALS patients.


  • The inferior longitudinal fasciculus: anatomy, function and surgical considerations

    by Ilyess Zemmoura, Eléonor Burkhardt, Guillaume Herbet

    Article: The inferior longitudinal fasciculus: anatomy, function and surgical considerations - Journal of Neurosurgical Sciences 2021 December;65(6):590-604 - Minerva Medica - Journals


  • Open Access

    Morocco as a possible source for acquisition of Rhinocladiella mackenziei

    by Baptiste Lafont Rapnouil, Jérémie F. Cohen, Eric Bailly, Louis Bernard, Dea Garcia-Hermoso, Fanny Lanternier, Catherine Horodyckid, Lucie Limousin, Ephrem Salamé, Ilyess Zemmoura, et al.

    Rhinocladiella mackenziei cerebral phaeohyphomycosis is a rare severe disease that has been typically described in the Middle East. Here, we report 2 cases of R. mackenziei cerebral phaeohyphomycosis in patients from Morocco, diagnosed and treated in France, and raise a concern about the ever-going extension of the area at risk for this devastating invasive fungal infection.